Brooklyn Beckham Calls Nicola: Money, Fame, and Family
A high-profile family quarrel during anniversary week highlights how money, branding, and personal ties intersect in ...
Which Funds To Use For Retirement Portfolio 2024
Choosing the right funds for a retirement portfolio requires balance of cost and coverage. Review 2024 options and practical selection tips.
26,319 articles
Economist Said ‘No Bubble’ Warns Chaos Ahead This Summer
A trusted market voice pivots from saying there’s no bubble to warning of growing chaos as IPO activity accelerates a...
Dividend Stocks Never Sell: 3 Picks to Hold Forever
Want anchors in a stormy market? Meet three dividend stocks never sell. These blue-chip picks blend reliable cash flo...
DOJ Pushes Retrial Tornado Cash Developer Roman Storm
The U.S. DOJ moves to retry Tornado Cash developer Roman Storm on key charges in SDNY, aiming to resolve unresolved c...
Pixelworks (PXLW) 2025 Earnings Outlook and Analysis
Pixelworks' 2025 earnings cycle highlights a niche semiconductor with rising AI-driven display capabilities. This art...
Duke Scientists Create Robot with 20 Legs and 360° Vision
Duke University researchers unveiled Argus, a 20-legged robot capable of moving in any direction. The breakthrough co...
IEO’s $0.55 Quarterly Dividend Faces a Test as Oil Rises
With oil prices near a year high, IEO’s $0.55 quarterly dividend is set to be tested by producer payouts and market s...
Stop Blaming Immigration U.S.: Devices Drive Social Media
A top psychologist says the decade-long drop in U.S. reading scores isn’t caused by immigration, but by pervasive dev...
Smartphones Help Explain the Drop in Birth Rates Today
A new working paper links the rise of smartphones to slower family formation, suggesting devices are reshaping when a...
With Just Words, Chair Signals Policy Shift in Markets
A seasoned financial writer explains how a president-defining stance from the new Fed chair can ripple through stocks...
Once-In-A-Decade Buying Opportunity This Growth Stock
As markets swing, a dominant growth stock may pull back while fundamentals stay strong. This guide explains how to sp...
CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status